Immunomodulatory effects of soluble CD5 on experimental tumor models

Modulation of antitumor immune responses by targeting immune checkpoint regulators has been proven successful in the treatment of many different tumors. Recent evidence shows that the lymphocyte receptor CD5 –a negative regulator of TCR-mediated signaling- may play a role in the anti-tumor immune re...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Inês T., Aranda, Fernando, Carreras, Esther, Andrés, Maria Velasco-de, Casadó-Llombart, Sergi, Martinez, Vanesa G., Lozano, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746133/
https://www.ncbi.nlm.nih.gov/pubmed/29296231
http://dx.doi.org/10.18632/oncotarget.22564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746133/
https://www.ncbi.nlm.nih.gov/pubmed/29296231
http://dx.doi.org/10.18632/oncotarget.22564

Ejemplares similares